-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
- Ambrx Biopharma Cayman, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $673K, a 227% increase year-over-year.
- Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2022 was $1.87M, a 7.58% increase from 2021.
- Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2021 was $1.74M, a 2.96% increase from 2020.
- Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2020 was $1.69M, a 3.05% increase from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)